Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis

ClinicalTrials.gov ID: NCT01682512

Public ClinicalTrials.gov record NCT01682512. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 6, 2026, 2:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy, Pharmacokinetics, and Safety of BI 695500 Versus Rituximab in Patients With Moderately to Severely Active Rheumatoid Arthritis: a Randomized, Double-blind, Parallel Arm, Multiple Dose, Active Comparator Trial.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objectives of this trial are (1) To show PK (Pharmacokinetic) similarity of BI 695500 to rituximab. (2)To establish statistical equivalence of efficacy of BI 695500 and rituximab, in patients with moderately to severely active RA (Rheumatoid Arthritis), based on the change in Disease Activity Score 28 (DAS28) score measured at 24 weeks compared to Baseline and the American College of Rheumatology 20% (ACR20) response rate at Week 24.

Study identification

NCT ID
NCT01682512
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
294 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 5, 2012 (Actual)
Primary completion
Nov 17, 2015 (Actual)
Completion
Oct 12, 2016 (Actual)
Last update posted
Jan 30, 2018

2012 – 2016

United States locations

U.S. sites
54
U.S. states
25
U.S. cities
51
Facility City State ZIP Site status
Rheumatology Associates Birmingham Alabama 35205 —
Achieve Clinical Research, LLC Birmingham Alabama 35216 —
Arizona Arthritis & Rheumatology Associates, P.C. Glendale Arizona 85304 —
Arizona Arthritis and Rheumatology Research, PLLC Mesa Arizona 85032 —
Arizona Arthritis and Rheumatology Research, PLLC Mesa Arizona 85202 —
Arizona Arthritis and Rheumatology Research, PLLC Phoenix Arizona 85307 —
Little Rock Diagnostic Clinic Little Rock Arkansas 72205 —
Medvin Clinical Research Covina California 91723 —
TriWest Research Associates, LLC El Cajon California 92020 —
Advanced Medical Research, LLC Lakewood California 90712 —
Premiere Clinical Research, LLC Lakewood California 90712 —
ProHealth Partners Long Beach California 90808 —
San Diego Arthritis Medical Clinic San Diego California 92108 —
Arthritis Center Medical Group Santa Maria California 93454 —
Westlake Medical Research Thousand Oaks California 91360 —
Inland Rheumatology Clinical Trials, Inc. Upland California 91786 —
Nascimento, Joao (Private Practice) Bridgeport Connecticut 06606 —
Avail Clinical Research, LLC DeLand Florida 32720 —
New Horizon Research Center Miami Florida 33175 —
Arthritis Associates, Inc. Orlando Florida 32804 —
Family Clinical Trials, Incorporated Pembroke Pines Florida 33026 —
Arthritis & Rheumatology Associates of Palm Beach Tampa Florida 33609 —
Lovelace Scientific Resources, Incorporated Venice Florida 34292 —
Coeur d'Alene Arthritis Clinical Trials Coeur d'Alene Idaho 83814 —
Institute of Arthritis Research Idaho Falls Idaho 83404 —
Apex Medical Research Chicago Illinois 60616 —
International Clinical Research Overland Park Kansas 66210 —
Columbia Medical Practice, PC Columbia Maryland 21045 —
Klein and Associates, M.D., P.A. Cumberland Maryland 21502 —
The Center for Rheumatology and Bone Research Wheaton Maryland 20902 —
Clinical Pharmacology Study Group Worcester Massachusetts 01605 —
West Michigan Rheumatology, PLLC Grand Rapids Michigan 49546 —
Arthritis Consultants, Inc St Louis Missouri 63141 —
Westroads Clinical Research Omaha Nebraska 68114 —
Summit Medical Group Clifton New Jersey 07012 —
Atlantic Coast Research Toms River New Jersey 08755 —
Albuquerque Center For Rheumatology Albuquerque New Mexico 87102 —
Arthritis and Osteoporosis Medical Associates, PLLC Brooklyn New York 11201 —
Box Arthritis & Rheumatology of the Carolinas Charlotte North Carolina 28210 —
Medication Management, LLC Greensboro North Carolina 27408 —
STAT Research, Incorporated Dayton Ohio 45417 —
Lynn Health Science Institute Oklahoma City Oklahoma 73112 —
Altoona Center for Clinical Research, P.C. Duncansville Pennsylvania 16635 —
Office of Dr. Ramesh C. Gupta Memphis Tennessee 38119 —
Center for Inflammatory Disease Nashville Tennessee 37203 —
ClinRX Research LLC Carrollton Texas 75007 —
Adriana Pop Moody Clinic PA Corpus Christi Texas 78404 —
Heartland Research Associates, LLC Houston Texas 77034 —
ClinRx Research LLC McKinney Texas 75069 —
Heartland Research Associates, LLC Webster Texas 77598 —
The Seattle Arthritis Clinic, PS Seattle Washington 98133 —
Tacoma Center for Arthritis Research, PS Tacoma Washington 98405-2395 —
Rheumatology and Pulmonary Clinic Beckley West Virginia 25801 —
Mountain State Clinical Research Clarksburg West Virginia 26301 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01682512, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 30, 2018 · Synced Oct 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01682512 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →